D43.9
Conditions
Interventions
Group 1: Patients receive a questionnaire during the informed consent session before and after a 3D model is shown that represents their pathological change
Sponsors
Klinik und Poliklinik für Neurochirurgie
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Tumors of the CNS to be treated electively - Written consent to the study by the patient or legal guardian if age < 18 years - Indication for surgical treatment of the CNS tumor given by the treating physicians in neurosurgery
Exclusion criteria
Exclusion criteria: - Tumors requiring emergency care - Written consent to study is missing - Contraindications for surgical treatment of the CNS tumors by the treating physicians in neurosurgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary endpoint is the investigation of improved information transfer between doctor and patient through the patient-specific 3D models, especially with regard to understanding their own disease, the impact on lifestyle and the planned therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| The costs and the time required for building and printing of the 3D models are to be recorded as secondary endpoints and a statement is to be made about the applicability in relation to the benefit in everyday clinical practice. | — |
Countries
Germany
Contacts
Public ContactFranziska Frank
Universitätsklinikum Leipzig, Klinik und Poliklinik für Neurochirurgie
Outcome results
None listed